PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor (Q39087858)
Jump to navigation
Jump to search
scientific article published on 3 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor |
scientific article published on 3 October 2013 |
Statements
1 reference
PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor (English)
1 reference
K Airiau
1 reference
F-X Mahon
1 reference
M Josselin
1 reference
M Jeanneteau
1 reference
F Belloc
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference